Skip to main content
PMC home page
Infection and Immunity logoLink to Infection and Immunity
. 1997 Aug;65(8):3328–3336. doi: 10.1128/iai.65.8.3328-3336.1997

Human papillomavirus type 16 virus-like particles expressed in attenuated Salmonella typhimurium elicit mucosal and systemic neutralizing antibodies in mice.

D Nardelli-Haefliger 1, R B Roden 1, J Benyacoub 1, R Sahli 1, J P Kraehenbuhl 1, J T Schiller 1, P Lachat 1, A Potts 1, P De Grandi 1
PMCID: PMC175471  PMID: 9234794

Abstract

Attenuated strains of Salmonella are attractive live vaccine candidates for eliciting mucosal as well as systemic immune responses. The ability to induce immune responses in the reproductive tract may be critical for the effectiveness of a prophylactic vaccine against genital human papillomaviruses (HPV), which are important etiologic agents in the development of cervical cancer. To examine the potential of a live Salmonella-based vaccine to prevent genital HPV infection, the L1 major capsid protein from HPV type 16 (HPV16) was constitutively expressed in the PhoPc strain of Salmonella typhimurium. As demonstrated by electron microscopy, the L1 protein expressed in these bacteria assembled into virus-like particles (VLPs) that resemble authentic papillomavirus virions. This is the first demonstration that papillomavirus VLPs can self-assemble in prokaryotes. BALB/c mice were immunized with the HPV16 L1 recombinant PhoPc strain by the oral and nasal routes. Despite a low stability of the L1-expressing plasmid in vivo, a double nasal immunization was effective in inducing L1-specific serum antibodies that recognized mainly native, but not disassembled, VLPs. These antibodies effectively neutralized HPV16 pseudotyped virions in an in vitro infectivity assay. Conformationally dependent anti-VLP immunoglobulin A (IgA) and IgG were also detected in oral and vaginal secretions, indicating that potentially protective antibody responses were elicited at mucosal sites. Recombinant attenuated Salmonella expressing HPV capsids may represent a promising vaccine candidate against genital HPV infection.

Full Text

The Full Text of this article is available as a PDF (682.0 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Banks L., Spence P., Androphy E., Hubbert N., Matlashewski G., Murray A., Crawford L. Identification of human papillomavirus type 18 E6 polypeptide in cells derived from human cervical carcinomas. J Gen Virol. 1987 May;68(Pt 5):1351–1359. doi: 10.1099/0022-1317-68-5-1351. [DOI] [PubMed] [Google Scholar]
  2. Bosch F. X., Manos M. M., Muñoz N., Sherman M., Jansen A. M., Peto J., Schiffman M. H., Moreno V., Kurman R., Shah K. V. Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. International biological study on cervical cancer (IBSCC) Study Group. J Natl Cancer Inst. 1995 Jun 7;87(11):796–802. doi: 10.1093/jnci/87.11.796. [DOI] [PubMed] [Google Scholar]
  3. Bouvet J. P., Bélec L., Pirès R., Pillot J. Immunoglobulin G antibodies in human vaginal secretions after parenteral vaccination. Infect Immun. 1994 Sep;62(9):3957–3961. doi: 10.1128/iai.62.9.3957-3961.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Breitburd F., Kirnbauer R., Hubbert N. L., Nonnenmacher B., Trin-Dinh-Desmarquet C., Orth G., Schiller J. T., Lowy D. R. Immunization with viruslike particles from cottontail rabbit papillomavirus (CRPV) can protect against experimental CRPV infection. J Virol. 1995 Jun;69(6):3959–3963. doi: 10.1128/jvi.69.6.3959-3963.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Davies D. H., Hill C. M., Rothbard J. B., Chain B. M. Definition of murine T helper cell determinants in the major capsid protein of human papillomavirus type 16. J Gen Virol. 1990 Nov;71(Pt 11):2691–2698. doi: 10.1099/0022-1317-71-11-2691. [DOI] [PubMed] [Google Scholar]
  6. Enders A. The influence of general, volatile anesthetics on the dynamic properties of model membranes. Biochim Biophys Acta. 1990 Nov 2;1029(1):43–50. doi: 10.1016/0005-2736(90)90434-p. [DOI] [PubMed] [Google Scholar]
  7. Hagensee M. E., Carter J. J., Wipf G. C., Galloway D. A. Immunization of mice with HPV vaccinia virus recombinants generates serum IgG, IgM, and mucosal IgA antibodies. Virology. 1995 Jan 10;206(1):174–182. doi: 10.1016/s0042-6822(95)80032-8. [DOI] [PubMed] [Google Scholar]
  8. Hagensee M. E., Yaegashi N., Galloway D. A. Self-assembly of human papillomavirus type 1 capsids by expression of the L1 protein alone or by coexpression of the L1 and L2 capsid proteins. J Virol. 1993 Jan;67(1):315–322. doi: 10.1128/jvi.67.1.315-322.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Hofmann K. J., Cook J. C., Joyce J. G., Brown D. R., Schultz L. D., George H. A., Rosolowsky M., Fife K. H., Jansen K. U. Sequence determination of human papillomavirus type 6a and assembly of virus-like particles in Saccharomyces cerevisiae. Virology. 1995 Jun 1;209(2):506–518. doi: 10.1006/viro.1995.1283. [DOI] [PubMed] [Google Scholar]
  10. Holt P. G., Haining S., Nelson D. J., Sedgwick J. D. Origin and steady-state turnover of class II MHC-bearing dendritic cells in the epithelium of the conducting airways. J Immunol. 1994 Jul 1;153(1):256–261. [PubMed] [Google Scholar]
  11. Hopkins S., Kraehenbuhl J. P., Schödel F., Potts A., Peterson D., de Grandi P., Nardelli-Haefliger D. A recombinant Salmonella typhimurium vaccine induces local immunity by four different routes of immunization. Infect Immun. 1995 Sep;63(9):3279–3286. doi: 10.1128/iai.63.9.3279-3286.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Jenison S. A., Yu X. P., Valentine J. M., Koutsky L. A., Christiansen A. E., Beckmann A. M., Galloway D. A. Evidence of prevalent genital-type human papillomavirus infections in adults and children. J Infect Dis. 1990 Jul;162(1):60–69. doi: 10.1093/infdis/162.1.60. [DOI] [PubMed] [Google Scholar]
  13. Kirnbauer R., Booy F., Cheng N., Lowy D. R., Schiller J. T. Papillomavirus L1 major capsid protein self-assembles into virus-like particles that are highly immunogenic. Proc Natl Acad Sci U S A. 1992 Dec 15;89(24):12180–12184. doi: 10.1073/pnas.89.24.12180. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Kirnbauer R., Chandrachud L. M., O'Neil B. W., Wagner E. R., Grindlay G. J., Armstrong A., McGarvie G. M., Schiller J. T., Lowy D. R., Campo M. S. Virus-like particles of bovine papillomavirus type 4 in prophylactic and therapeutic immunization. Virology. 1996 May 1;219(1):37–44. doi: 10.1006/viro.1996.0220. [DOI] [PubMed] [Google Scholar]
  15. Kirnbauer R., Taub J., Greenstone H., Roden R., Dürst M., Gissmann L., Lowy D. R., Schiller J. T. Efficient self-assembly of human papillomavirus type 16 L1 and L1-L2 into virus-like particles. J Virol. 1993 Dec;67(12):6929–6936. doi: 10.1128/jvi.67.12.6929-6936.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Krul M. R., Tijhaar E. J., Kleijne J. A., Van Loon A. M., Nievers M. G., Schipper H., Geerse L., Van der Kolk M., Steerenberg P. A., Mooi F. R. Induction of an antibody response in mice against human papillomavirus (HPV) type 16 after immunization with HPV recombinant Salmonella strains. Cancer Immunol Immunother. 1996 Sep;43(1):44–48. doi: 10.1007/s002620050302. [DOI] [PubMed] [Google Scholar]
  17. Kuper C. F., Koornstra P. J., Hameleers D. M., Biewenga J., Spit B. J., Duijvestijn A. M., van Breda Vriesman P. J., Sminia T. The role of nasopharyngeal lymphoid tissue. Immunol Today. 1992 Jun;13(6):219–224. doi: 10.1016/0167-5699(92)90158-4. [DOI] [PubMed] [Google Scholar]
  18. Kutteh W. H., Blackwell R. E., Gore H., Kutteh C. C., Carr B. R., Mestecky J. Secretory immune system of the female reproductive tract. II. Local immune system in normal and infected fallopian tube. Fertil Steril. 1990 Jul;54(1):51–55. [PubMed] [Google Scholar]
  19. Kutteh W. H., Hatch K. D., Blackwell R. E., Mestecky J. Secretory immune system of the female reproductive tract: I. Immunoglobulin and secretory component-containing cells. Obstet Gynecol. 1988 Jan;71(1):56–60. [PubMed] [Google Scholar]
  20. Kutteh W. H., Mestecky J. Secretory immunity in the female reproductive tract. Am J Reprod Immunol. 1994 Jan;31(1):40–46. doi: 10.1111/j.1600-0897.1994.tb00845.x. [DOI] [PubMed] [Google Scholar]
  21. Köchel H. G., Sievert K., Monazahian M., Mittelstädt-Deterding A., Teichmann A., Thomssen R. Antibodies to human papillomavirus type-16 in human sera as revealed by the use of prokaryotically expressed viral gene products. Virology. 1991 Jun;182(2):644–654. doi: 10.1016/0042-6822(91)90605-b. [DOI] [PubMed] [Google Scholar]
  22. Leavitt A. D., Roberts T. M., Garcea R. L. Polyoma virus major capsid protein, VP1. Purification after high level expression in Escherichia coli. J Biol Chem. 1985 Oct 15;260(23):12803–12809. [PubMed] [Google Scholar]
  23. Londoño L. P., Chatfield S., Tindle R. W., Herd K., Gao X. M., Frazer I., Dougan G. Immunisation of mice using Salmonella typhimurium expressing human papillomavirus type 16 E7 epitopes inserted into hepatitis B virus core antigen. Vaccine. 1996 Apr;14(6):545–552. doi: 10.1016/0264-410x(95)00216-n. [DOI] [PubMed] [Google Scholar]
  24. Lowy D. R., Kirnbauer R., Schiller J. T. Genital human papillomavirus infection. Proc Natl Acad Sci U S A. 1994 Mar 29;91(7):2436–2440. doi: 10.1073/pnas.91.7.2436. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. McDermott M. R., Bienenstock J. Evidence for a common mucosal immunologic system. I. Migration of B immunoblasts into intestinal, respiratory, and genital tissues. J Immunol. 1979 May;122(5):1892–1898. [PubMed] [Google Scholar]
  26. McLean C. S., Churcher M. J., Meinke J., Smith G. L., Higgins G., Stanley M., Minson A. C. Production and characterisation of a monoclonal antibody to human papillomavirus type 16 using recombinant vaccinia virus. J Clin Pathol. 1990 Jun;43(6):488–492. doi: 10.1136/jcp.43.6.488. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Miller S. I., Mekalanos J. J. Constitutive expression of the phoP regulon attenuates Salmonella virulence and survival within macrophages. J Bacteriol. 1990 May;172(5):2485–2490. doi: 10.1128/jb.172.5.2485-2490.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Nardelli-Haefliger D., Kraehenbuhl J. P., Curtiss R., 3rd, Schodel F., Potts A., Kelly S., De Grandi P. Oral and rectal immunization of adult female volunteers with a recombinant attenuated Salmonella typhi vaccine strain. Infect Immun. 1996 Dec;64(12):5219–5224. doi: 10.1128/iai.64.12.5219-5224.1996. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Neutra M. R., Pringault E., Kraehenbuhl J. P. Antigen sampling across epithelial barriers and induction of mucosal immune responses. Annu Rev Immunol. 1996;14:275–300. doi: 10.1146/annurev.immunol.14.1.275. [DOI] [PubMed] [Google Scholar]
  30. Pilacinski W. P., Glassman D. L., Glassman K. F., Reed D. E., Lum M. A., Marshall R. F., Muscoplat C. C., Faras A. J. Immunization against bovine papillomavirus infection. Ciba Found Symp. 1986;120:136–156. doi: 10.1002/9780470513309.ch10. [DOI] [PubMed] [Google Scholar]
  31. Roden R. B., Greenstone H. L., Kirnbauer R., Booy F. P., Jessie J., Lowy D. R., Schiller J. T. In vitro generation and type-specific neutralization of a human papillomavirus type 16 virion pseudotype. J Virol. 1996 Sep;70(9):5875–5883. doi: 10.1128/jvi.70.9.5875-5883.1996. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Rose R. C., Reichman R. C., Bonnez W. Human papillomavirus (HPV) type 11 recombinant virus-like particles induce the formation of neutralizing antibodies and detect HPV-specific antibodies in human sera. J Gen Virol. 1994 Aug;75(Pt 8):2075–2079. doi: 10.1099/0022-1317-75-8-2075. [DOI] [PubMed] [Google Scholar]
  33. Salunke D. M., Caspar D. L., Garcea R. L. Self-assembly of purified polyomavirus capsid protein VP1. Cell. 1986 Sep 12;46(6):895–904. doi: 10.1016/0092-8674(86)90071-1. [DOI] [PubMed] [Google Scholar]
  34. Sasagawa T., Pushko P., Steers G., Gschmeissner S. E., Hajibagheri M. A., Finch J., Crawford L., Tommasino M. Synthesis and assembly of virus-like particles of human papillomaviruses type 6 and type 16 in fission yeast Schizosaccharomyces pombe. Virology. 1995 Jan 10;206(1):126–135. doi: 10.1016/s0042-6822(95)80027-1. [DOI] [PubMed] [Google Scholar]
  35. Schödel F., Milich D. R., Will H. Hepatitis B virus nucleocapsid/pre-S2 fusion proteins expressed in attenuated Salmonella for oral vaccination. J Immunol. 1990 Dec 15;145(12):4317–4321. [PubMed] [Google Scholar]
  36. Schödel F. Oral vaccination using recombinant bacteria. Semin Immunol. 1990 Sep;2(5):341–349. [PubMed] [Google Scholar]
  37. Schödel F., Peterson D., Zheng J., Jones J. E., Hughes J. L., Milich D. R. Structure of hepatitis B virus core and e-antigen. A single precore amino acid prevents nucleocapsid assembly. J Biol Chem. 1993 Jan 15;268(2):1332–1337. [PubMed] [Google Scholar]
  38. Sminia T., van der Brugge-Gamelkoorn G. J., Jeurissen S. H. Structure and function of bronchus-associated lymphoid tissue (BALT). Crit Rev Immunol. 1989;9(2):119–150. [PubMed] [Google Scholar]
  39. Srinivasan J., Tinge S., Wright R., Herr J. C., Curtiss R., 3rd Oral immunization with attenuated Salmonella expressing human sperm antigen induces antibodies in serum and the reproductive tract. Biol Reprod. 1995 Aug;53(2):462–471. doi: 10.1095/biolreprod53.2.462. [DOI] [PubMed] [Google Scholar]
  40. Suzich J. A., Ghim S. J., Palmer-Hill F. J., White W. I., Tamura J. K., Bell J. A., Newsome J. A., Jenson A. B., Schlegel R. Systemic immunization with papillomavirus L1 protein completely prevents the development of viral mucosal papillomas. Proc Natl Acad Sci U S A. 1995 Dec 5;92(25):11553–11557. doi: 10.1073/pnas.92.25.11553. [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. Zhou J., Sun X. Y., Davies H., Crawford L., Park D., Frazer I. H. Definition of linear antigenic regions of the HPV16 L1 capsid protein using synthetic virion-like particles. Virology. 1992 Aug;189(2):592–599. doi: 10.1016/0042-6822(92)90582-a. [DOI] [PubMed] [Google Scholar]
  42. Zhou J., Sun X. Y., Frazer I. H. Glycosylation of human papillomavirus type 16 L1 protein. Virology. 1993 May;194(1):210–218. doi: 10.1006/viro.1993.1251. [DOI] [PubMed] [Google Scholar]

Articles from Infection and Immunity are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES